{"id":"https://openalex.org/W2801613992","doi":"https://doi.org/10.2147/ppa.s151736","title":"Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement","display_name":"Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement","alternate_titles":[],"publication_year":2018,"publication_date":"2018-05-01","ids":{"openalex":"https://openalex.org/W2801613992","doi":"https://doi.org/10.2147/ppa.s151736","mag":"2801613992","pmid":"https://pubmed.ncbi.nlm.nih.gov/29765207","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5944456"},"language":"en","primary_location":{"id":"doi:10.2147/ppa.s151736","doi":"https://doi.org/10.2147/ppa.s151736","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ppa.s151736","pdf_url":"https://www.dovepress.com/getfile.php?fileID=41934","source":{"id":"https://openalex.org/S66639021","display_name":"Patient Preference and Adherence","issn_l":"1177-889X","issn":["1177-889X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Patient Preference and Adherence","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2801613992"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=41934","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064872622","display_name":"Francesco Giorgino","orcid":"https://orcid.org/0000-0001-7372-2678","observed_orcids":["https://orcid.org/0000-0001-7372-2678"]},"institutions":[{"id":"https://openalex.org/I5561750","display_name":"University of Bari Aldo Moro","ror":"https://ror.org/027ynra39","country_code":"IT","type":"education","lineage":["https://openalex.org/I5561750"]}],"countries":["IT"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Francesco Giorgino","raw_affiliation_strings":["Department of Emergency and Organ Transplantation, Section of Internal Medicine, Endocrinology, Andrology, and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy"],"raw_orcid":"https://orcid.org/0000-0001-7372-2678","affiliations":[{"raw_affiliation_string":"Department of Emergency and Organ Transplantation, Section of Internal Medicine, Endocrinology, Andrology, and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy","institution_ids":["https://openalex.org/I5561750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006947224","display_name":"Alfred Penfornis","orcid":"https://orcid.org/0000-0002-9635-7674","observed_orcids":["https://orcid.org/0000-0002-9635-7674"]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I4210113338","display_name":"Centre Hospitalier Sud Francilien","ror":"https://ror.org/0246mbd04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210113338"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alfred Penfornis","raw_affiliation_strings":["Service d'Endocrinologie, Diab\u00e9tologie, et Maladies M\u00e9taboliques, Centre Hospitalier Sud-Francilien de Corbeil-Essonnes, Universit\u00e9 Paris-Sud, Orsay, France","Centre Hospitalier Sud-Francilien de Corbeil-essonnes, Universit\u00e9 Paris-Sud, Orsay, France;","Diab\u00e9tologie, et Maladies M\u00e9taboliques,","Service d'endocrinologie,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service d'Endocrinologie, Diab\u00e9tologie, et Maladies M\u00e9taboliques, Centre Hospitalier Sud-Francilien de Corbeil-Essonnes, Universit\u00e9 Paris-Sud, Orsay, France","institution_ids":["https://openalex.org/I102197404","https://openalex.org/I4210113338"]},{"raw_affiliation_string":"Centre Hospitalier Sud-Francilien de Corbeil-essonnes, Universit\u00e9 Paris-Sud, Orsay, France;","institution_ids":["https://openalex.org/I102197404","https://openalex.org/I4210113338"]},{"raw_affiliation_string":"Diab\u00e9tologie, et Maladies M\u00e9taboliques,","institution_ids":[]},{"raw_affiliation_string":"Service d'endocrinologie,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089497324","display_name":"Valeria Pechtner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Valeria Pechtner","raw_affiliation_strings":["Lilly Diabetes, Eli Lilly & Company, Neuilly-sur-Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Diabetes, Eli Lilly & Company, Neuilly-sur-Seine, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060140104","display_name":"Raffaella Gentilella","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210164813","display_name":"Eli Lilly (Italy)","ror":"https://ror.org/05d0e9y67","country_code":"IT","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210164813"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Raffaella Gentilella","raw_affiliation_strings":["Eli Lilly Italia, Sesto Fiorentino, Italy","Lilly italia, Sesto Fiorentino, italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly Italia, Sesto Fiorentino, Italy","institution_ids":["https://openalex.org/I4210164813"]},{"raw_affiliation_string":"Lilly italia, Sesto Fiorentino, italy","institution_ids":["https://openalex.org/I4210164813"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005241900","display_name":"Antonella Corcos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210164813","display_name":"Eli Lilly (Italy)","ror":"https://ror.org/05d0e9y67","country_code":"IT","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210164813"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Antonella Corcos","raw_affiliation_strings":["Eli Lilly Italia, Sesto Fiorentino, Italy","Lilly italia, Sesto Fiorentino, italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly Italia, Sesto Fiorentino, Italy","institution_ids":["https://openalex.org/I4210164813"]},{"raw_affiliation_string":"Lilly italia, Sesto Fiorentino, italy","institution_ids":["https://openalex.org/I4210164813"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5064872622"],"corresponding_institution_ids":["https://openalex.org/I5561750"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":1.7121,"has_fulltext":true,"cited_by_count":73,"citation_normalized_percentile":{"value":0.84324324,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"Volume 12","issue":null,"first_page":"707","last_page":"719"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.7440999746322632,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.7440999746322632,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.24449999630451202,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10793","display_name":"Diabetes Management and Education","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.984000027179718},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9679999947547913},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.8690000176429749},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9419999718666077},{"id":"https://openalex.org/keywords/drug-delivery-devices","display_name":"drug delivery devices","score":0.7200000286102295},{"id":"https://openalex.org/keywords/once-weekly-dosing","display_name":"weekly dosing","score":0.6510000228881836},{"id":"https://openalex.org/keywords/dulaglutide","display_name":"dulaglutide","score":0.7620000243186951},{"id":"https://openalex.org/keywords/albiglutide","display_name":"albiglutide","score":0.9549999833106995},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.9440000057220459},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9900000095367432},{"id":"https://openalex.org/keywords/pharmaceutical-formulations","display_name":"drug formulation","score":0.7509999871253967},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8109999895095825}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9511481523513794},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.8696930408477783},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.7723970413208008},{"id":"https://openalex.org/C2779829264","wikidata":"https://www.wikidata.org/wiki/Q21011228","display_name":"Dulaglutide","level":5,"score":0.7047315835952759},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6367129683494568},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.5857695937156677},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5196743607521057},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5165130496025085},{"id":"https://openalex.org/C2778176773","wikidata":"https://www.wikidata.org/wiki/Q2976049","display_name":"Drug class","level":3,"score":0.5060750842094421},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.46893027424812317},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.44210365414619446},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4240185618400574},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3733312785625458},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.33967146277427673},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28732842206954956},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.2235400676727295},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.13279619812965393},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.11152079701423645}],"mesh":[],"locations_count":7,"locations":[{"id":"doi:10.2147/ppa.s151736","doi":"https://doi.org/10.2147/ppa.s151736","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ppa.s151736","pdf_url":"https://www.dovepress.com/getfile.php?fileID=41934","source":{"id":"https://openalex.org/S66639021","display_name":"Patient Preference and Adherence","issn_l":"1177-889X","issn":["1177-889X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Patient Preference and Adherence","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4870984","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5944456","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5944456","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5944456/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Patient Prefer Adherence","raw_type":"Text"},{"id":"pmid:29765207","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29765207","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Patient preference and adherence","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:ff758afbf6fd4d54a7f28ee959c7215c","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/ff758afbf6fd4d54a7f28ee959c7215c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Patient Preference and Adherence, Vol Volume 12, Pp 707-719 (2018)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/38160","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/adherence-to-antihyperglycemic-medications-and-glucagon-like-peptide-1-peer-reviewed-article-PPA","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Review"},{"id":"pmh:oai:ricerca.uniba.it:11586/222541","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/11586/222541","pdf_url":null,"source":{"id":"https://openalex.org/S4377196296","display_name":"CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I5561750","host_organization_name":"University of Bari Aldo Moro","host_organization_lineage":["https://openalex.org/I5561750"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.2147/ppa.s151736","doi":"https://doi.org/10.2147/ppa.s151736","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ppa.s151736","pdf_url":"https://www.dovepress.com/getfile.php?fileID=41934","source":{"id":"https://openalex.org/S66639021","display_name":"Patient Preference and Adherence","issn_l":"1177-889X","issn":["1177-889X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Patient Preference and Adherence","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2801613992.pdf","grobid_xml":"https://content.openalex.org/works/W2801613992.grobid-xml"},"referenced_works_count":83,"referenced_works":["https://openalex.org/W108299943","https://openalex.org/W653611238","https://openalex.org/W1498870695","https://openalex.org/W1556067192","https://openalex.org/W1837867596","https://openalex.org/W1845225129","https://openalex.org/W1885494502","https://openalex.org/W1934542946","https://openalex.org/W1955429230","https://openalex.org/W1969146158","https://openalex.org/W1984207232","https://openalex.org/W1987620175","https://openalex.org/W1988255364","https://openalex.org/W2002890924","https://openalex.org/W2005316799","https://openalex.org/W2005318736","https://openalex.org/W2009830637","https://openalex.org/W2010033044","https://openalex.org/W2010559564","https://openalex.org/W2011998736","https://openalex.org/W2027073279","https://openalex.org/W2030136986","https://openalex.org/W2040535455","https://openalex.org/W2040639706","https://openalex.org/W2043037892","https://openalex.org/W2044383241","https://openalex.org/W2047187313","https://openalex.org/W2049701806","https://openalex.org/W2050153005","https://openalex.org/W2055194261","https://openalex.org/W2055754603","https://openalex.org/W2059764669","https://openalex.org/W2062227887","https://openalex.org/W2062882918","https://openalex.org/W2065319712","https://openalex.org/W2072979222","https://openalex.org/W2078382172","https://openalex.org/W2088274037","https://openalex.org/W2092551595","https://openalex.org/W2096416969","https://openalex.org/W2096733280","https://openalex.org/W2104922575","https://openalex.org/W2106049537","https://openalex.org/W2107074825","https://openalex.org/W2113033841","https://openalex.org/W2115977452","https://openalex.org/W2116154858","https://openalex.org/W2120271909","https://openalex.org/W2121737909","https://openalex.org/W2128034652","https://openalex.org/W2129218314","https://openalex.org/W2139062201","https://openalex.org/W2141001773","https://openalex.org/W2145044717","https://openalex.org/W2149435665","https://openalex.org/W2151939796","https://openalex.org/W2155441883","https://openalex.org/W2156108549","https://openalex.org/W2158350833","https://openalex.org/W2160088494","https://openalex.org/W2161569080","https://openalex.org/W2166886145","https://openalex.org/W2172193326","https://openalex.org/W2202879106","https://openalex.org/W2207970920","https://openalex.org/W2313228492","https://openalex.org/W2326795281","https://openalex.org/W2330048999","https://openalex.org/W2330289041","https://openalex.org/W2471756691","https://openalex.org/W2480832378","https://openalex.org/W2534292815","https://openalex.org/W2556785537","https://openalex.org/W2571824959","https://openalex.org/W2584571831","https://openalex.org/W2585146202","https://openalex.org/W2586129535","https://openalex.org/W2606513490","https://openalex.org/W2738595939","https://openalex.org/W2746562707","https://openalex.org/W2789732774","https://openalex.org/W4236047095","https://openalex.org/W4245460707"],"related_works":["https://openalex.org/W3128342452","https://openalex.org/W2415073266","https://openalex.org/W2914708635","https://openalex.org/W2167077969","https://openalex.org/W7221450060","https://openalex.org/W4380149100","https://openalex.org/W2994599039","https://openalex.org/W4401399644","https://openalex.org/W2912404136"],"abstract_inverted_index":{"Adherence":[0],"to":[1,17,32,43,101,104,190,194,236,241,248,278],"antihyperglycemic":[2,105,242],"medications":[3],"is":[4,68,112,167,245],"often":[5],"suboptimal":[6],"in":[7,45,77,92,118,172,208,228,267,282],"patients":[8,198],"with":[9,169,199],"type":[10,83,200,283],"2":[11,84,201,284],"diabetes,":[12],"and":[13,23,38,52,65,72,90,94,137,146,214,221],"this":[14,39,132,176],"can":[15,73,147],"contribute":[16],"poor":[18],"glycemic":[19],"control,":[20],"increased":[21],"hospitalization,":[22],"the":[24,61,119,250,268],"development":[25],"of":[26,60,122,131,144,162,178,182,270],"diabetic":[27],"complications.":[28],"Reported":[29],"adherence":[30,56,103,171,240],"rates":[31],"antihyperglycemics":[33],"vary":[34],"widely":[35],"among":[36,98,197],"studies,":[37],"may":[40,57,225,275],"be":[41,74,148,226],"related":[42],"differences":[44],"methodology":[46],"for":[47,108],"measuring":[48],"adherence,":[49,261],"patient":[50,230],"populations,":[51],"other":[53],"factors.":[54],"Poor":[55],"occur":[58],"regardless":[59],"specific":[62],"regimen":[63],"used":[64],"whether":[66],"therapy":[67,196],"oral":[69],"or":[70],"injectable,":[71],"especially":[75,107],"common":[76],"chronic,":[78],"asymptomatic":[79],"conditions,":[80],"such":[81,153],"as":[82,155],"diabetes.":[85,202,285],"More":[86],"convenient":[87],"drug-administration":[88],"regimens":[89],"advances":[91,266],"formulations":[93],"delivery":[95,185,215,258,269],"devices":[96],"are":[97,128],"strategies":[99],"shown":[100,189],"improve":[102,237],"therapy,":[106],"injectable":[109,195],"therapy.":[110],"This":[111,203],"exemplified":[113],"by":[114,263],"technological":[115,265],"developments":[116],"made":[117],"drug":[120,209,256],"class":[121,177],"glucagon-like":[123,271],"peptide":[124,272],"1-receptor":[125,273],"agonists,":[126,274],"which":[127],"a":[129,183],"focus":[130],"narrative":[133],"review.":[134],"Dulaglutide,":[135],"albiglutide,":[136],"prolonged-release":[138],"exenatide":[139],"have":[140],"an":[141],"extended":[142],"duration":[143],"action":[145],"administered":[149],"once":[150],"weekly,":[151],"whereas":[152],"agents":[154],"liraglutide":[156],"require":[157],"once-daily":[158,165],"administration.":[159],"The":[160],"convenience":[161],"once-weekly":[163],"versus":[164],"administration":[166],"associated":[168],"better":[170],"real-world":[173],"studies":[174],"involving":[175],"agent.":[179],"Moreover,":[180],"provision":[181],"user-friendly":[184],"device":[186],"has":[187],"been":[188],"overcome":[191],"initial":[192],"resistance":[193],"suggests":[204],"that":[205],"recent":[206,264],"innovations":[207],"formulation":[210],"(eg,":[211,217],"ready-to-use":[212],"formulations)":[213],"systems":[216],"single-dose":[218],"prefilled":[219],"pens":[220],"hidden,":[222],"ready-attached":[223],"needles)":[224],"instrumental":[227],"encouraging":[229],"acceptance.":[231],"For":[232],"physicians":[233],"who":[234],"aim":[235],"their":[238],"patients'":[239],"medications,":[243],"it":[244],"thus":[246,276],"important":[247],"consider":[249],"patient's":[251],"therapeutic":[252],"experience":[253],"(treatment":[254],"frequency,":[255],"formulation,":[257],"device).":[259],"Better":[260],"powered":[262],"lead":[277],"improved":[279],"clinical":[280],"outcomes":[281]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2801613992","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":17},{"year":2019,"cited_by_count":9}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2018-05-17T00:00:00"}
